Integral Health Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Integral Health Asset Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25,000	Closed	-$389K	–	88
2021 Q4	$389K	Sell	25,000 -40,000	-62%	-$764K	0.11%	70
2021 Q3	$1.46M	Sell	65,000 -20,000	-24%	-$439K	0.42%	58
2021 Q2	$1.94M	Buy	85,000 +20,000	+31%	+$421K	0.53%	54
2021 Q1	$1.34M	Buy	65,000 +15,000	+30%	+$341K	0.38%	58
2020 Q4	$1.38M	Hold	50,000	–	–	0.41%	53
2020 Q3	$703K	Buy	+50,000	New	+$930K	0.22%	71

Other funds holding MYOV

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Integral Health Asset Management's MYOV Position: Q1 2022 in Review

Integral Health Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q1 2022, closing a stake of 25,000 shares — an estimated $389K sold.

Integral Health Asset Management first reported a position in MYOV in Q3 2020 and held it in 6 quarters. The position peaked at $1.94M in Q2 2021. 89 funds tracked by Wall St. Rank hold MYOV as of Q1 2022.

Integral Health Asset Management reported no remaining Myovant Sciences Ltd. position as of Q1 2022 after selling out during the quarter.
Integral Health Asset Management sold 25,000 Myovant Sciences Ltd. shares in Q1 2022, an estimated $389K.
Integral Health Asset Management first reported a position in Myovant Sciences Ltd. in Q3 2020 and held it in 6 quarters.
Integral Health Asset Management's Myovant Sciences Ltd. position peaked at $1.94M in Q2 2021.
89 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2022.

Based on Integral Health Asset Management's 13F filing for Q1 2022, filed 12 May 2022.